about
Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial).Anosognosia in Alzheimer's disease--the petrified self.Regional cerebral blood flow abnormalities in depressed patients with cognitive impairmentCognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease.Unawareness of memory impairment in dementia: a population-based study.Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group.Emotional reactivity and awareness of task performance in Alzheimer's disease.Emotional reactivity to film material in Alzheimer's disease.Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study.A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.Cortical thickness, surface area and volume measures in Parkinson's disease, multiple system atrophy and progressive supranuclear palsyDonepezil and memantine for moderate-to-severe Alzheimer's disease.Neuropsychological and behavioral disturbance correlates of unawareness of memory impairment in dementia: a population-based study.Cognitive behavioural therapy (CBT) for carers of patients with Parkinson's disease: a preliminary randomised controlled trial.Parkinsonism following bilateral lesions of the globus pallidus: performance on a variety of motor tasks shows similarities with Parkinson's diseaseApathy in Parkinson's disease.The assessment of fatigue: a practical guide for clinicians and researchers.Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysisRumination and behavioural factors in Parkinson's disease depressionDiagnosing Alzheimer's disease--non-clinicians and computerised algorithms together are as accurate as the best clinical practice.Clinical diagnostic criteria for dementia associated with Parkinson's disease.Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCTParkinson's Impulse-Control Scale for the Severity Rating of Impulse-Control Behaviors in Parkinson's Disease: A Semistructured Clinical Assessment Tool.Management of impulse control disorders in Parkinson's disease: Controversies and future approachesPerceptions of symptoms and expectations of advanced therapy for Parkinson's disease: preliminary report of a Patient-Reported Outcome tool for Advanced Parkinson's disease (PRO-APD).Cognitive behavioural interventions for depression in chronic neurological conditions: a systematic review.Psychotherapy and pharmacotherapy interventions to reduce distress or improve well-being in people with amyotrophic lateral sclerosis: A systematic review.Randomised, waiting list controlled trial of cognitive-behavioural therapy for persistent postconcussional symptoms after predominantly mild-moderate traumatic brain injury.Why don't older adults with subjective memory complaints seek help?The Parkinson fatigue scale.Infusion Therapies and Development of Impulse Control Disorders in Advanced Parkinson Disease: Clinical Experience After 3 Years' Follow-up.Thinking about motor fluctuations: An examination of metacognitions in Parkinson's disease.Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.Determining the minimum clinically important differences for outcomes in the DOMINO trial.The dopaminergic basis of cognitive and motor performance in Alzheimer's disease.Motor phenotypes, medication and mood: further associations with impulsive behaviours in Parkinson's disease.Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study.Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease.
P50
Q30380032-271F6EDC-ACF3-48DE-8B25-D893D4F8D884Q33493737-618D899C-556C-4BB2-9529-C9FEC62C09F3Q33591429-B763B4B4-3CE5-4B8E-8353-2084EF4258D7Q33615626-6AF96E40-A1F1-41AA-A9AE-7EF8D25E4962Q33636523-6D1CDA20-1F37-4CE6-B08F-0148784676D0Q34129719-BA3CCD1F-B00F-466F-85D5-3ABF881B4E5FQ34245237-F51425F1-827C-43FA-9D92-BAC9774F97C3Q34275289-8D04B94A-E445-4320-ACA7-789A67ED3B3FQ34504048-DA4CEA1F-497E-441C-959C-F781F3F61088Q34535482-8E9E29D4-536D-4B62-9BC8-F3B455A4E865Q34611889-F8342419-149E-488D-8647-65EE5955687FQ34612291-C2356998-98DA-4CCF-8564-EE76904A9BECQ34636487-8FDE5410-A11A-4357-BEEE-BC529D82F40DQ35204190-F6D531D3-1419-4AFD-926B-C1B237439B0BQ35487049-208E3B06-23AF-43CE-A917-E0A7FE599F44Q35487265-4D355D23-29B6-4EC6-A6C4-9F92E6A3B760Q35560120-35AD9E1F-A7CC-4479-9202-03855BB61540Q35689136-E0A26C14-8053-4E48-9BDD-3F37C936348CQ36419572-9582379D-E568-44D0-A957-29B144A58A7EQ36698247-4AB81FC8-8ECD-4003-8276-459DB7C29C37Q36832420-A69E1B68-E49F-4C53-AD4A-ADB86CA53A63Q36836828-40D5A057-1CBC-42B9-8978-5555161E689EQ37039871-B35CA004-B6BE-4C88-8C7C-ADCE90850AACQ37295359-19E50C14-7C2C-4EB8-B1CF-AF63F9F4D310Q37316401-C3B5233D-8ABA-457A-8F89-78F1A07219F6Q37361959-E97BED9F-A151-4A94-81FE-25EBB2D5DE96Q37532255-DC435392-7E7D-4ADB-A932-C419A9DE17B4Q38380402-8C2C6BBC-F127-41EE-8E88-473AC7F08A5BQ38547111-B109871A-45AC-4758-BF60-471CF1931962Q39519031-38D97B08-6579-4AD4-9E2C-82EC176BD075Q39751745-9E3D5514-E70A-4761-8D77-AF91229F80B2Q40458495-A87C59AC-A589-4C0A-B0BA-E918E4F8788DQ40746369-D1DE2C12-C421-40BF-8122-F034B9409760Q40922701-CDCEF344-45EB-4470-BDE6-B5887C84DD17Q41169867-7CF4F91F-7373-41A6-9342-5B61655F8353Q42675662-FB4C4D6B-4EAF-44C6-9F7B-F67EF1E98420Q43242089-434CD71F-6EAA-4A8E-AAF2-9CB1FDA01D2DQ44703897-35315563-9535-4ACC-A88B-E6342CE88536Q44956018-A2B476F7-CD78-4D92-8AB3-EA8E7F231592Q45157469-253581D1-8BE7-44E2-951C-C770E3FE307E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Richard G Brown
@ast
Richard G Brown
@en
Richard G Brown
@es
Richard G Brown
@nl
Richard G Brown
@sl
রিচার্ড জি ব্রাউন
@bn
type
label
Richard G Brown
@ast
Richard G Brown
@en
Richard G Brown
@es
Richard G Brown
@nl
Richard G Brown
@sl
রিচার্ড জি ব্রাউন
@bn
altLabel
Richard Brown
@en
Schulze S
@en
prefLabel
Richard G Brown
@ast
Richard G Brown
@en
Richard G Brown
@es
Richard G Brown
@nl
Richard G Brown
@sl
রিচার্ড জি ব্রাউন
@bn
P106
P21
P31
P4012
P496
0000-0001-9021-0172